Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.29 USD
Change Today 0.00 / 0.00%
Volume 0.0
REMI On Other Exchanges
Symbol
Exchange
OTC US
As of 8:10 PM 05/21/15 All times are local (Market data is delayed by at least 15 minutes).

Executive Profile*

Guy De Vreese

Chairman, Chief Executive Officer, Chief Executive Officer of Remedent NV and President of Remedent NV, Remedent, Inc.
AgeTotal Calculated CompensationThis person is connected to 4 board members in 3 different organizations across 3 different industries.

See Board Relationships
59--
As of Fiscal Year 2014

Background*

Mr. Guy De Vreese has been the Chairman of Remedent Inc., since April 1, 2002, Chief Executive Officer since December 10, 2008 and President since June 2001. Mr. De Vreese has been the Chairman of the Board at Remedent NV, a subsidiary of Remedent Inc. since April 1, 2002 and also serves as its Chief Executive Officer. Mr. De Vreese has been the President of Remedent NV since June 2001. He served as the Chief Executive Officer of Lident, N.V., from 1996 to February 1999. ...

Read Full Background

Corporate Headquarters*

Zuiderlaan 1-3 box 8
Ghent, East Flanders 9000

Belgium

Phone: 32 9 241 58 80
Fax: 32 9 241 58 99

Board Members Memberships*

Former Chairman of the Board
Chairman, Chief Executive Officer, Chief Executive Officer of Remedent NV and President of Remedent NV
Chairman and Chief Executive Officer
Director

Education*

There is no Education data available.

Other Affiliations*

Annual Compensation*

There is no Annual Compensation data available.

Stock Options*

Exercisable Options100,000
Total Number of Options100,000

Total Compensation*

There is no Total Compensation data available.
*Data is at least as current as the most recent Definitive Proxy.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
REMI:US $0.29 USD 0.00

COMPETITOR COMPENSATION

There is no Competitor Compensation data available.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact REMEDENT INC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.